BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21985118)

  • 1. Risk perceptions, worry, and attitudes about genetic testing for breast cancer susceptibility.
    Cameron LD; Reeve J
    Psychol Health; 2006; 21(2):211-30. PubMed ID: 21985118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responses to Information about Psychosocial Consequences of Genetic Testing for Breast Cancer Susceptibility: Influences of Cancer Worry and Risk Perceptions.
    Cameron LD; Diefenbach MA
    J Health Psychol; 2001 Jan; 6(1):47-59. PubMed ID: 22049237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coping after cancer: risk perceptions, worry, and health behaviors among colorectal cancer survivors.
    Mullens AB; McCaul KD; Erickson SC; Sandgren AK
    Psychooncology; 2004 Jun; 13(6):367-76. PubMed ID: 15188444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interest, awareness, and perceptions of genetic testing among Hispanic family members of breast cancer survivors.
    Ramirez AG; Aparicio-Ting FE; de Majors SS; Miller AR
    Ethn Dis; 2006; 16(2):398-403. PubMed ID: 17682241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interest in genetic testing among first-degree relatives of breast cancer patients.
    Lerman C; Seay J; Balshem A; Audrain J
    Am J Med Genet; 1995 Jul; 57(3):385-92. PubMed ID: 7677139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interest in breast cancer chemoprevention among older women.
    Tjia J; Micco E; Armstrong K
    Breast Cancer Res Treat; 2008 Apr; 108(3):435-53. PubMed ID: 17554628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk perceptions and worry about cancer: does gender make a difference?
    McQueen A; Vernon SW; Meissner HI; Rakowski W
    J Health Commun; 2008; 13(1):56-79. PubMed ID: 18307136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the knowledge and attitudes regarding genetic testing for breast cancer risk in our region of southeastern Georgia.
    MacNew HG; Rudolph R; Brower ST; Beck AN; Meister EA
    Breast J; 2010; 16(2):189-92. PubMed ID: 20030654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive and affective determinants of decisions to attend a group psychosocial support program for women with breast cancer.
    Cameron LD; Booth RJ; Schlatter M; Ziginskas D; Harman JE; Benson SR
    Psychosom Med; 2005; 67(4):584-9. PubMed ID: 16046371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of counseling Ashkenazi Jewish women about breast cancer risk.
    Bowen DJ; Burke W; Culver JO; Press N; Crystal S
    Cultur Divers Ethnic Minor Psychol; 2006 Jan; 12(1):45-56. PubMed ID: 16594854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
    Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
    Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes toward colon cancer gene testing: survey of relatives of colon cancer patients.
    Petersen GM; Larkin E; Codori AM; Wang CY; Booker SV; Bacon J; Giardiello FM; Boyd PA
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):337-44. PubMed ID: 10207638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of worry after breast cancer risk assessment: 6-year follow-up of the TRACE study cohort.
    Brain K; Parsons E; Bennett P; Cannings-John R; Hood K
    Psychooncology; 2011 Sep; 20(9):984-91. PubMed ID: 20677331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer.
    Watson M; Lloyd S; Davidson J; Meyer L; Eeles R; Ebbs S; Murday V
    Br J Cancer; 1999 Feb; 79(5-6):868-74. PubMed ID: 10070883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How interested is the public in genetic testing for colon cancer susceptibility? Report of a cross-sectional population survey.
    Graham ID; Logan DM; Hughes-Benzie R; Evans WK; Perras H; McAuley LM; Laupacis A; Stern H
    Cancer Prev Control; 1998 Aug; 2(4):167-72. PubMed ID: 10093629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological aspects of cancer screening in high-risk populations.
    Kash KM; Dabney MK
    Med Pediatr Oncol; 2001 May; 36(5):519-24. PubMed ID: 11340606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between knowledge and attitudes about genetic testing for cancer risk in the United States.
    Rose A; Peters N; Shea JA; Armstrong K
    J Health Commun; 2005 Jun; 10(4):309-21. PubMed ID: 16036738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation in breast cancer risk counseling among women with a family history.
    Bowen D; McTiernan A; Burke W; Powers D; Pruski J; Durfy S; Gralow J; Malone K
    Cancer Epidemiol Biomarkers Prev; 1999 Jul; 8(7):581-5. PubMed ID: 10428194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.